Department of Comparative Biomedical Sciences, Royal Veterinary College, London, UK; School of Applied Sciences, University of Brighton, UK.
Department of Comparative Biomedical Sciences, Royal Veterinary College, London, UK; Clinical and Experimental Endocrinology, KU, Leuven, Belgium.
Bone. 2023 Nov;176:116868. doi: 10.1016/j.bone.2023.116868. Epub 2023 Aug 6.
Extracellular pyrophosphate (PP) is well known for its fundamental role as a physiochemical mineralisation inhibitor. However, information about its direct actions on bone cells remains limited. This study shows that PP decreased osteoclast formation and resorptive activity by ≤50 %. These inhibitory actions were associated with reduced expression of genes involved in osteoclastogenesis (Tnfrsf11a, Dcstamp) and bone resorption (Ctsk, Car2, Acp5). In osteoblasts, PP present for the entire (0-21 days) or latter stages of culture (7-21/14-21 days) decreased bone mineralisation by ≤95 %. However, PP present for the differentiation phase only (0-7/0-14 days) increased bone formation (≤70 %). Prolonged treatment with PP resulted in earlier matrix deposition and increased soluble collagen levels (≤2.3-fold). Expression of osteoblast (RUNX2, Bglap) and early osteocyte (E11, Dmp1) genes along with mineralisation inhibitors (Spp1, Mgp) was increased by PP (≤3-fold). PP levels are regulated by tissue non-specific alkaline phosphatase (TNAP) and ecto-nucleotide pyrophosphatase/phosphodiesterase 1 (NPP1). PP reduced NPP1 expression in both cell types whereas TNAP expression (≤2.5-fold) and activity (≤35 %) were increased in osteoblasts. Breakdown of extracellular ATP by NPP1 represents a key source of PP. ATP release from osteoclasts and osteoblasts was decreased ≤60 % by PP and by a selective TNAP inhibitor (CAS496014-12-2). Pertussis toxin, which prevents Gα subunit activation, was used to investigate whether G-protein coupled receptor (GPCR) signalling mediates the effects of PP. The actions of PP on bone mineralisation, collagen production, ATP release, gene/protein expression and osteoclast formation were abolished or attenuated by pertussis toxin. Together these findings show that PP, modulates differentiation, function and gene expression in osteoblasts and osteoclasts. The ability of PP to alter ATP release and NPP1/TNAP expression and activity indicates that cells can detect PP levels and respond accordingly. Our data also raise the possibility that some actions of PP on bone cells could be mediated by a Gα-linked GPCR.
细胞外焦磷酸盐 (PP) 作为一种重要的理化矿物质抑制物,其基本作用广为人知。然而,关于其对骨细胞的直接作用的信息仍然有限。本研究表明,PP 可将破骨细胞的形成和吸收活性降低 ≤50%。这些抑制作用与参与破骨细胞生成的基因(Tnfrsf11a、Dcstamp)和骨吸收基因(Ctsk、Car2、Acp5)表达的减少有关。在成骨细胞中,在整个培养过程(0-21 天)或后期阶段(7-21/14-21 天)存在的 PP 将骨矿化减少 ≤95%。然而,仅在分化阶段存在的 PP(0-7/0-14 天)增加了骨形成(≤70%)。用 PP 进行长期治疗会导致基质更早沉积并增加可溶性胶原蛋白水平(≤2.3 倍)。PP 增加了成骨细胞(RUNX2、Bglap)和早期成骨细胞(E11、Dmp1)基因以及矿化抑制剂(Spp1、Mgp)的表达(≤3 倍)。PP 水平受组织非特异性碱性磷酸酶 (TNAP) 和外核苷酸焦磷酸酶/磷酸二酯酶 1 (NPP1) 的调节。PP 降低了两种细胞类型中 NPP1 的表达,而 TNAP 的表达(≤2.5 倍)和活性(≤35%)在成骨细胞中增加。NPP1 对细胞外 ATP 的分解代表了 PP 的一个关键来源。PP 将破骨细胞和成骨细胞释放的 ATP 减少 ≤60%,并减少了选择性 TNAP 抑制剂(CAS496014-12-2)的释放。百日咳毒素用于研究 G 蛋白偶联受体 (GPCR) 信号是否介导 PP 的作用,该毒素可防止 Gα 亚基的激活。PP 对骨矿化、胶原蛋白产生、ATP 释放、基因/蛋白表达和破骨细胞形成的作用被百日咳毒素阻断或减弱。这些发现表明,PP 可调节成骨细胞和破骨细胞的分化、功能和基因表达。PP 改变 ATP 释放和 NPP1/TNAP 表达和活性的能力表明细胞可以检测到 PP 水平并做出相应反应。我们的数据还提出了一种可能性,即 PP 对骨细胞的某些作用可能由与 Gα 相连的 GPCR 介导。